0001062993-23-003837.txt : 20230216 0001062993-23-003837.hdr.sgml : 20230216 20230216182148 ACCESSION NUMBER: 0001062993-23-003837 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230214 FILED AS OF DATE: 20230216 DATE AS OF CHANGE: 20230216 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Campbell Michael Gerard CENTRAL INDEX KEY: 0001934174 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-41403 FILM NUMBER: 23639765 MAIL ADDRESS: STREET 1: C/O COMERA LIFE SCIENCES HOLDINGS, INC. STREET 2: 12 GILL STREET, SUITE 4650 CITY: WOBURN STATE: MA ZIP: 01801 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Comera Life Sciences Holdings, Inc. CENTRAL INDEX KEY: 0001907685 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 874706968 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 12 GILL STREET STREET 2: SUITE 4650 CITY: WOBURN STATE: MA ZIP: 01801 BUSINESS PHONE: (617)871-2101 MAIL ADDRESS: STREET 1: 12 GILL STREET STREET 2: SUITE 4650 CITY: WOBURN STATE: MA ZIP: 01801 4 1 form4.xml STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES X0306 4 2023-02-14 0001907685 Comera Life Sciences Holdings, Inc. CMRA 0001934174 Campbell Michael Gerard C/O COMERA LIFE SCIENCES HOLDINGS, INC. 12 GILL STREET, SUITE 4650 WOBURN MA 01801 0 1 0 0 EVP & CFO Stock Option (Right to Purchase) 1.30 2023-02-14 4 A 0 25000 0 A 2033-02-14 Common Stock 25000 25000 D 25% of the shares underlying the stock option vest on February 14, 2024, with the remaining shares vesting on a monthly basis on the 14th day of each month thereafter, in each case, subject to continuous service to the issuer, such that the option shall be fully vested on February 14, 2027. /s/ Ryan M. Rourke Reed, Attorney-in-Fact 2023-02-16